申请人:Neurocrine Biosciences, Inc.
公开号:US20040192676A1
公开(公告)日:2004-09-30
Compounds which function as melanocortin receptor ligands and having utility in the treatment of melanocortin receptor-based disorders. The compounds have the following structure (I):
1
including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein A, B, m, n,p, q, r, s, t, R
1a
, R
1b
, R
2
, R
3a
, R
3b
, R
3c
, R
4
, X, Y
1
, Y
2
, and Y
3
are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as methods relating to the use thereof, are also disclosed.
具有治疗基于黑色素细胞激素受体的疾病作用的化合物。该化合物具有以下结构(I):包括立体异构体,前药和药学上可接受的盐,其中A,B,m,n,p,q,r,s,t,R1a,R1b,R2,R3a,R3b,R3c,R4,X,Y1,Y2和Y3的定义如本文所述。还公开了含有结构(I)化合物的药物组合物,以及与其使用相关的方法。